OTTAWA, ON , Sept. 28, 2023 /CNW/ - Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for individuals six months of age and older. Health Canada received ...
KANAZAWA, Japan , Sept. 26, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in the Journal of Physical Chemistry Letters high-speed atomic force microscopy studies that shed light on the possible role of the open reading ...
VANCOUVER, BC , Sept. 25, 2023 /PRNewswire/ - In the relentless battle against the ever-evolving COVID-19 pandemic, Gene Bio Medical (GBM), a leading player in the field of medical innovations, is taking center stage with its remarkable ...
ROCHESTER, N.Y. , Sept. 18, 2023 /PRNewswire/ -- OyaGen, Inc. Today the company announced publication in Antiviral Research of studies evaluating the mechanism of action of its proprietary COVID therapeutic in preclinical development. ...
OTTAWA, ON , Sept. 12, 2023 /CNW/ - Health Canada has authorized the use of the Moderna SPIKEVAX™ COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older. Health Canada received Moderna's ...
Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging ...
SHERBROOKE, QC , Aug. 21, 2023 /CNW/ - Immune Biosolutions, a Canadian biotech company based in Sherbrooke , reached a new milestone in developing the first inhaled antibody-based treatment against COVID-19. The prestigious medical ...
The active treatment was four times more effective at reducing fatigue compared to a control, and increased energy levels twice that of the control LONDON , July 19, 2023 /PRNewswire/ -- A promising medical study has just been ...
The Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York City is pleased to announce that CastleVax, Inc., has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus ...
SAN DIEGO , July 11, 2023 /PRNewswire/ -- The U.S.-Mexico Border Philanthropy Partnership (BPP), the Consulate General of Mexico in San Diego , the California Department of Public Health (CDPH), and Cross Border Xpress (CBX) announce ...
Amid rising concerns over the new Covid-19 variants, known as FLiRT, health experts reassured the publicthat there is no necessity for panic or additional caution. Insights on FLiRT Variants The FLiRT variants, which majorly ...
In the ongoing battle against COVID-19 , the emergence of new variants has kept the world on edge. Among the latest variants of concern is FLiRT, an offshoot of the JN.1 lineage of the Omicron variant . With cases surging in the United States, ...
Long COVID manifests differently in children across different age groups, presenting a complex spectrum of symptoms that demand attention and understanding. From infants to school-going children and adolescents, each demographic grapples with its ...
In a significant turn of events, British pharmaceutical giant AstraZeneca has acknowledged that its COVID-19 vaccine , Covishield, can lead to rare side effects. This admission, reported by The Telegraph (UK), comes amidst mounting ...
The COVID-19 pandemic disruptions and restrictions resulted in only "modest" delays in developmental milestones for infants and children aged 5 years and younger ( ). In a report published in JAMA Pediatrics, investigators evaluated ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers